Levetiracetam Brillpharma 100mg/ml Oral Solution

Neurology: Anti-epileptic

Therapeutically indicated as:

  1. Monotherapy–in treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed epilepsy.
  2. Adjunctive therapy –
    • In treatment of partial onset seizures with or without secondary generalisation in adults, adolescents, children and infants from 1 month of age with epilepsy.
    • In treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.
    • in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.1
Strength 100mg/ml 100mg/ml 100mg/ml
Pack Size 300 ml, 10 ml syringe, 4+ years 150 ml, 3 ml syringe, 6-48 months 150 ml, 1 ml syringe, 1-6 months
Measuring Device 10 ml graduated oral syringe and an adaptor for the syringe 3 ml graduated oral syringe and an adaptor for the syringe 1 ml graduated oral syringe and an adaptor for the syringe
Regulatory Status POM POM POM
Flavour Grape Grape Grape
Suitable for Vegetarians Yes Yes Yes
GTIN 5060712420065 5060712420058 5060712420041
PIP code 124-4870 124-5364 124-5372

1 Summary of Product Characteristics (SPCs) and Patient Information Leaflets (PILs) can be found on the EMC website: https://www.medicines.org.uk/emc/product/13839/smpc

Manufacturing

Our quality and safety teams monitor and analyse each stage of the production and distribution process to make sure our products are of the highest quality. The application of Good Manufacturing Practice (GMP) means that we have the appropriate standards and procedures in place to help us achieve this.

How to report adverse events

Adverse events should be reported.

If you are based in the UK, reporting forms and information can be found at: https://yellowcard.mhra.gov.uk.

Adverse events should also be reported to Brill Pharma
Tel: 0044 (0) 1582 545500 Email: info@brillpharma.co.uk

If you are based outside of the UK, please report adverse events to Brill Pharma using the contact details provided above.

Have a question?

If you have a question about Brill Pharma or any products in our range please get in touch

Tel: 0044 (0) 1582 545500 Email: info@brillpharma.co.uk

Job Number: BLL-007-004Date of Preparation: March 2023